Published
The FDA approved Biogen’s Aducanumab after its own independent recommended that it be rejected.
- Category
- World
- Tags
- Aducanumab, Alzheimer's, Biogen
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
01:12
First patient receives Biogen Alzheimer's drug
-
06:20
What parents need to know about newly approved COVID vaccines for children under age 5
-
02:48
'This is not a cure' -doctor on Alzheimer's drug
-
01:46
Drug to treat agitation in Alzheimer’s patients approved in Canada
-
03:53
New drug can slow the development of Alzheimer's
-
04:50
FDA approves new drug to slow progression of Alzheimer's
-
14:45
State Of Play: Can businesses survive the three newly approved “killer” taxes?
-
02:54
How will this new drug change Alzheimer's treatment?
-
02:19
New Alzheimer's drug approved by US regulator
-
02:54
What to know about the newly FDA-approved pill for postpartum depression | ABCNL
-
03:59
FDA-approved drug brings hope to Americans living with Alzheimer's
-
12:34
An Alzheimer’s Drug That Doesn’t Treat Alzheimer’s?
-
01:55
U.S. FDA approves experimental Alzheimer's drug
-
16:02
What’s The Controversy Behind Biogen’s Alzheimer’s Drug?
-
01:32
Biogen CEO to step down after Alzheimer's drug snags
-
04:04
New Alzheimer's drug 'opens door for more funding'
-
06:00
Why the FDA approved a controversial Alzheimer's drug
-
04:42
US FDA approves 1st new Alzheimer’s drug in nearly 20 years
-
02:45
US approves controversial new Alzheimer’s drug
-
12:54
How will newly approved antiviral treatment affect the Omicron wave?
-
01:33
Breakthrough or risk? FDA approves Alzheimer's drug
-
02:43
New Alzheimer's drug is first 'to target the root cause'
Loading...